Article
The forgotten woman's cancer: vulvar squamous cell carcinoma (VSCC) and a targeted approach to therapy.
Annals of oncology : official journal of the European Society for Medical Oncology - 1 Sept 2016
Clancy A A, Spaans J N, Weberpals J I
Abstract excerpt
BACKGROUND: The incidence of vulvar squamous cell carcinoma (VSCC) has been on the rise since the 1990s. There has been no new treatment for advanced and recurrent disease in decades, with most women succumbing to the disease. Despite two distinct etiologies of VSCC, human papillomavirus (HPV)-associated and HPV-independent disease, there is no difference in therapeutic options. METHODS: A literature review was...
Topics
- Biomarkers, Tumor
- Carcinoma, Squamous Cell
- Female
- Gene Expression Regulation, Neoplastic
- Humans
- Molecular Targeted Therapy
- Mutation
- Neoplasm Proteins
- Papillomaviridae
- Vulvar Neoplasms
